Status:
TERMINATED
A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
Lead Sponsor:
Thomas Jefferson University
Conditions:
Pancreatic Neoplasms
Biliary Tract Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this trial is to determine whether a mucosa-to-mucosa technique of pancreaticojejunostomy will improve the pancreatic fistula rate.
Detailed Description
Pancreaticoduodenectomy (PD) is a commonly performed operative procedure which is used in selected patients with benign and malignant diseases of the pancreas and periampullary region. The procedure i...
Eligibility Criteria
Inclusion
- Patients must have undergone pancreaticoduodenectomy.
- Must have pancreatic remnant remaining in place (body and tail).
- Must be candidate for reconstruction by pancreaticojejunostomy by one of the two techniques described below.
- Must have an identifiable pancreatic duct which can be used for a duct-to-mucosa anastomosis.
Exclusion
- Patients undergoing total pancreatectomy.
- Patients undergoing PD who have had previous left-sided pancreatic resection.
- Failure to sign informed consent.
- Failure to identify the pancreatic duct.
- Pregnant patients.
Key Trial Info
Start Date :
May 25 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 12 2008
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT00359320
Start Date
May 25 2006
End Date
July 12 2008
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States, 19107